Vaccine potential of two previously uncharacterized African swine fever virus isolates from southern Africa and heterologous cross protection of an avirulent European isolate

dc.contributor.authorSouto, Ricardo
dc.contributor.authorMutowembwa, Paidamwoyo
dc.contributor.authorVan Heerden, J.
dc.contributor.authorFosgate, Geoffrey Theodore
dc.contributor.authorHeath, Livio Edward
dc.contributor.authorVosloo, Wilna
dc.date.accessioned2016-05-05T13:14:24Z
dc.date.available2016-05-05T13:14:24Z
dc.date.issued2016-04
dc.description.abstractAfrican swine fever (ASF) is a mostly fatal viral infection of domestic pigs for which there is no vaccine available. The disease is endemic to most of sub-Saharan Africa, causes severe losses and threatens food security in large parts of the continent. Naturally occurring attenuated ASF viruses have been tested as vaccine candidates, but protection was variable depending on the challenge virus. In this study, the virulence of two African isolates, one from a tick vector and the other from an indigenous pig, was determined in domestic pigs to identify a potential vaccine strain for southern Africa. Neither isolate was suitable as the tick isolate was moderately virulent and the indigenous pig virus was highly virulent. The latter was subsequently used as heterologous challenge in pigs first vaccinated with a naturally attenuated isolate previously isolated in Portugal. Although a statistically significant reduction in death rate and virus load was observed compared with unvaccinated pigs post-challenge, all pigs succumbed to infection and died.en_ZA
dc.description.departmentProduction Animal Studiesen_ZA
dc.description.departmentVeterinary Tropical Diseasesen_ZA
dc.description.librarianhb2016en_ZA
dc.description.sponsorshipWellcome Trust (Project number 210 183. 183 AHDW03/04).en_ZA
dc.description.urihttp://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1865-1682en_ZA
dc.identifier.citationSouto, R, Mutowembwa, P, Van Heerden, J, Fosgate, GT, Heath, L & Vosloo, W 2016, 'Vaccine potential of two previously uncharacterized African swine fever virus isolates from southern Africa and heterologous cross protection of an avirulent European isolate', Transboundary and Emerging Diseases, vol. 63, no. 2, pp. 224-231.en_ZA
dc.identifier.issn1865-1674 (print)
dc.identifier.issn1865-1682 (online)
dc.identifier.other10.1111/tbed.12250
dc.identifier.other6603440077
dc.identifier.urihttp://hdl.handle.net/2263/52489
dc.language.isoenen_ZA
dc.publisherWileyen_ZA
dc.rights© 2014 The Authors. Transboundary and Emerging Diseases Published by Blackwell Verlag GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.en_ZA
dc.subjectVirulenceen_ZA
dc.subjectAfrican isolatesen_ZA
dc.subjectPathologyen_ZA
dc.subjectVaccinationen_ZA
dc.subjectAfrican swine feveren_ZA
dc.subjectASF
dc.subjectASFV
dc.subjectAfrican swine fever virus
dc.titleVaccine potential of two previously uncharacterized African swine fever virus isolates from southern Africa and heterologous cross protection of an avirulent European isolateen_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Souto_Vaccine_2016.pdf
Size:
251.57 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: